A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioblastoma Multiforme of Brain · Glioma · Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Patrick Grogan, MD) · Patrick.grogan@moffitt.org · 813-745-8000
Contact: Principal Investigator (Patrick Grogan, MD)
Northwestern Medicine, Chicago, Illinois, United States
Contact: Study coordinator (Ditte Primdahl, MD) · 312-695-1202
NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Alexandra Miller, MD) · cancertrials@nyulangone.org · (212) 731-6267
Contact: Principal Investigator (Alexandra Miller, MD, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Glioma · Glioblastoma · Recurrent Glioma

Abroad (travel likely)RecruitingPHASE1

Iowa City, United States

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Central Nervous System Neoplasms · Glioblastoma · Gliosarcoma, Adult

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

GBM · Glioblastoma Multiforme (GBM) · Glioblastoma Multiforme of Brain

Abroad (travel likely)RecruitingPHASE1

Toronto, Canada

Implantable Microdevice In Primary Brain Tumors

Grade II Glioma · Grade III Glioma · Grade IV Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Boston, United States